Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Hepatitis Diagnostic Tests Market Forecast: What Market Value Is Expected By 2030?
The market for hepatitis diagnostic tests has experienced robust expansion lately, projecting a rise from $4.93 billion in 2025 to $5.21 billion in 2026, demonstrating a compound annual growth rate of 5.7%. Factors contributing to this historical growth include the proliferation of hepatitis screening initiatives, an uptick in laboratory testing quantities, heightened awareness surrounding viral hepatitis, enhanced accessibility to diagnostic facilities, and the establishment of consistent testing methodologies.
Anticipate robust expansion within the hepatitis diagnostic tests sector over the forthcoming years, with projections indicating a market valuation of $6.72 billion by 2030, fueled by a compound annual growth rate (CAGR) of 6.6%. This projected surge is largely attributable to a confluence of factors, including a heightened demand for decentralized diagnostic capabilities, escalating investments in sophisticated molecular testing methodologies, the proliferation of home-testing options, an intensified emphasis on preemptive disease identification, and a growing application of these tests in settings with limited resources. Key developments shaping this period are anticipated to encompass a greater uptake of rapid diagnostic kits, increased utilization of molecular diagnostic technologies, deeper integration of automated laboratory systems, the broadening scope of point-of-care testing solutions, and a more pronounced focus on achieving diagnosis that is both early and precise.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13153&type=smp
Hepatitis Diagnostic Tests Market Development Factors: Which Trends Are Supporting Demand?
Augmenting volumes of blood transfusions and donations are anticipated to serve as a significant catalyst for the expansion of the hepatitis diagnostic test market. The symbiotic relationship between blood transfusions and donations involves individuals voluntarily contributing blood, which undergoes rigorous collection and testing before being administered to patients needing supplementary blood components for various medical circumstances, including surgical recovery, emergency situations, or disease management. Essential for safeguarding recipients, hepatitis diagnostic tests are employed to meticulously screen donated blood, thereby ensuring its safety prior to transfusion. Illustratively, data from August 2023, as reported by the Royal College of Pathologists in the UK, highlights blood transfusion as the most prevalent procedure among inpatients, with an annual issuance and transfusion of almost two million blood components across England, incurring expenses exceeding £300 million (equivalent to approximately $390.69 million). Consequently, the escalating frequency of both blood transfusions and donations directly fuels the demand within the hepatitis diagnostic test market.
Hepatitis Diagnostic Tests Market Segmentation And Category Breakdown
The hepatitis diagnostic tests market covered in this report is segmented –
1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy
2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies
3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users
Subsegments:
1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)
3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy
Hepatitis Diagnostic Tests Market Transformation Trends: Which Innovations Are Driving Change?
Leading entities within the hepatitis diagnostic test sector are concentrating on the creation of advanced automated immunoassay solutions, exemplified by the Elecsys HCV Duo, with the objective of delivering dependable client support. These automated immunoassays represent laboratory methodologies that leverage automated platforms and specific equipment to manage every stage of the immunoassay process, encompassing sample preparation, reagent blending, incubation periods, signal detection, and the computation of outcomes. A pertinent illustration occurred in July 2023 when Roche Diagnostics India, a prominent biotechnology research firm based in India, introduced the Elecsys HCV Duo. This groundbreaking product stands as India’s inaugural commercially accessible, fully automated immunoassay, facilitating the simultaneous and distinct measurement of both hepatitis C virus (HCV) antigen and antibody concentrations from an identical human plasma or serum specimen. Furthermore, this approach supports single-specimen analysis, thereby simplifying the diagnostic pathway and diminishing the need for additional testing appointments, consequently alleviating the strain on healthcare infrastructure.
Hepatitis Diagnostic Tests Market Competitive Analysis Of Major Industry Participants
Major companies operating in the hepatitis diagnostic tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH
Access The Complete Hepatitis Diagnostic Tests Market Report:
https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report
Hepatitis Diagnostic Tests Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the hepatitis diagnostic tests market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
